Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.23.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Grant revenue $ 131,521 $ 86,987
Operating expenses:    
Research and development 10,072,684 10,586,144
General and administrative 4,474,465 5,271,861
Total operating expenses 14,547,149 15,858,005
Loss from operations (14,415,628) (15,771,018)
Other income (expense):    
Interest income 135,900 75,847
Interest expense (15,103) (15,756)
Local business tax (5,140) (1,357)
Other income 11,582 670
Total other income, net 127,239 59,404
Loss before income taxes (14,288,389) (15,711,614)
Income tax benefit
Net loss $ (14,288,389) $ (15,711,614)
Basic and diluted net loss per share $ (7.11) $ (8.09)
Shares used to compute basic and diluted net loss per share 2,009,234 1,943,131